Discipline

Psychology (155) Economies and finances (108) Biological anthropology (50) Demography (23) Sociology (19) Social Anthropology and ethnology (6) Political science (5) Communication sciences (4) Law (3) Management (2) Gender studies (2) Art and art history (2) Methods and statistics (1) Linguistics (1) History (1) History, Philosophy and Sociology of Sciences (1) Geography (1) Education (1) Classical studies (1) Archaeology and Prehistory (1)

Type

Articles (360) Conferences and symposiums (27) Reviews (22) Books and book chapters (3)

Co-author

Date

Collection

Keyword

Treatment (250) Patients (244) Patients (234) Human beings (214) therapy (213) Therapeutics (212) cohort (186) Swiss (172) adult (143) adult (143)  (142) Methods (142) infection (134) Older people (131) Infection (129) years (121) risk (107) Risk (107) Switzerland (103) Switzerland (102) time (97) Time (97) virus (95) Use (92) Analysis (80) Population (80) analysis (78) age (77) Age (77) Ci (Chinese poetry) (76)

Documents written by (390) | is about (0)

Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
I.C. Schoepf et al. (Nov 2, 2021)
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.
P. Thoueille et al. (Sep 9, 2021)
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.
C.W. Thorball et al. (Aug 1, 2021)
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
L. Veloza et al. (Jun 19, 2021)
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
H. Nguyen et al. (Jun 1, 2021)
Transplantation de microbiote fécal : de l’évidence aux réalités du terrain [Fecal microbiota transplantation: from the evidence to the realty of the field]
A. Ballif et al. (Apr 14, 2021)
The influence of human genetic variation on Epstein-Barr virus sequence diversity.
S. Rüeger et al. (Feb 25, 2021)
Epidemiology of sexually transmitted infections among female sex workers in Switzerland: a local, exploratory, cross-sectional study
M. Cavassini et al. (Dec 14, 2020)
Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
C.W. Thorball et al. (Dec 1, 2020)
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.
C. Wan et al. (Nov 2, 2020)
Self-reported Neurocognitive Impairment in People Living With Human Immunodeficiency Virus (HIV): Characterizing Clusters of Patients With Similar Changes in Self-reported Neurocognitive Impairment, 2013-2017, in the Swiss HIV Cohort Study.
K. Kusejko et al. (Jul 27, 2020)
Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
L.G. Dietrich et al. (Feb 14, 2020)
VIH: prévention, traitement et perspectives [Novelties in HIV prevention and treatment in 2019]
E. Kampouri et al. (Jan 15, 2020)
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients.
I.A. Abela et al. (Jan 2, 2020)
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.
P. Courlet et al. (Jan 1, 2020)
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
P. Courlet et al. (Jan, 2020)
The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
I. Locatelli et al. (Jan, 2020)
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.
P. Courlet et al. (Jan, 2020)
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy.
C. Barceló et al. (Jan, 2020)
Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque.
K. Darling et al. (Jan, 2020)
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
B. Surial et al. (Oct 10, 2019)
Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study.
A. Christe et al. (Sep 23, 2019)
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.
C. Barcelo et al. (Sep 1, 2019)
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
P. Courlet et al. (Sep 1, 2019)
HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected.
H. Nguyen et al. (Aug 15, 2019)

next